Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)

Alan L. Ho, Nathan R. Foster, Alex J. Zoroufy, Jordan D. Campbell, Francis Worden, Katharine Price, Douglas Adkins, Daniel W. Bowles, Hyunseok Kang, Barbara Burtness, Eric Sherman, Roscoe Morton, Luc G.T. Morris, Zaineb Nadeem, Nora Katabi, Pamela Munster, Gary K. Schwartz